FGF2 and cancer: While cancer cells upregulated endogenous fibroblast growth factor (FGF)-2 and became spontaneously resistant to a kinase inhibitor drug vemurafenib when cultured inside microchambers64, mouse embryonic stem cells maintained pluripotency inside microchambers by producing endogenous leukemia inhibitory factor (LIF)65.